Tristar Wellness Solutions Inc. (TWSI)
Tristar Wellness Solutions Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Portland, OR, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $56,000. On trailing twelve-month figures it carries a trailing P/E of -10.00, a net margin of 0.0%. Its beta of 9.91 implies it has historically moved more than the broad market.
TriStar Wellness Solutions Inc. specializes in the development, commercialization, and sale of various wound care products. The company's diverse portfolio extends to include skincare and other items specifically designed for pregnant and nursing women, marketed under the Beaute de Maman brand. They also provide solutions for bleeding and wound management, catering to a wide range of clients including surgical teams, general healthcare providers, consumers, and military markets. A key innovation from TriStar is its "Delivery Device with Invertible Diaphragm," a specialized medical applicator engineered for the safe and non-damaging internal administration of medicaments and other devices within the body. Furthermore, the company develops over-the-counter products aimed at itch suppression, and it is also involved in the development, manufacturing, and marketing of additional medical devices focused on wound care and infection control. Originally incorporated as BioPack Environmental Solutions, Inc., the company officially changed its name to TriStar Wellness Solutions, Inc. in January 2013. Based in Portland, Oregon, TriStar Wellness Solutions, Inc. ultimately faced financial difficulties, leading to a voluntary petition for liquidation under Chapter 7, filed on January 15, 2016, in the U.S. Bankruptcy Court for the District of Oregon.
Tristar Wellness Solutions Inc. is most often compared with the following Healthcare names: